From Roadmap to Reality: Validating NAMs for FDA's Plan to Phase Out Animal Testing 

By Yiguang Zhu | May 15th, 2025

“The FDA and the broader scientific community recognize NAMs as a means to obtain 'faster and more accurate human risk assessments' while reducing animal use.”

Image by ChatGPT